{
    "nctId": "NCT00353717",
    "briefTitle": "Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma",
    "officialTitle": "Phase II of Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 25,
    "primaryOutcomeMeasure": "tumor markers tumor size by ct",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with metastatic breast carcinoma of the basal like subtype with available biopsy for analysis and ECOG PS of 2 or less\n\nExclusion Criteria:\n\n* Pregnancy\n* BUN, blood creatinine, AST, ALT \\> X3 of upper limits of normal\n* More than previous 2 chemotherapy lines in the metastatic settings or the use of previous inhibitors of EGFR",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}